Healthcare News and Research

Latest Healthcare News and Research

Myriad myRisk test solves overlap dilemma between hereditary cancer syndromes

Myriad Genetics, Inc. today presented several clinical studies on the Myriad myRisk- Hereditary Cancer test at the 2014 American Society of Clinical Oncology annual meeting in Chicago, Illinois.

2 Jun 2014

Pivotal clinical validation study of Myriad myPath Melanoma test presented at ASCO 2014

Myriad Genetics, Inc. today presented results from a pivotal clinical validation study of the Myriad myPath- Melanoma test at the 2014 American Society of Clinical Oncology annual meeting in Chicago, Ill.

2 Jun 2014

ImmunoGen reports favorable clinical results from STARLYTE Phase II trial of SAR3419 for DLBCL

ImmunoGen, Inc., a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced the presentation of favorable clinical findings with SAR3419 (coltuximab ravtansine) from the STARLYTE Phase II trial in diffuse large B-cell lymphoma (DLBCL).

2 Jun 2014

Memorial Sloan Kettering Cancer Center, Quest Diagnostics partner for cancer tests

Memorial Sloan Kettering Cancer Center, the world's oldest and largest private cancer center, and Quest Diagnostics, the world's leading provider of diagnostic information services, today announced a joint collaboration that will utilize MSK's clinical and research insights into gene mutations associated with solid tumors.

From Quest Diagnostics 2 Jun 2014

Ultrasound beam 'tweezers' can grip and manipulate tiny clusters of cells

Pioneering 'tweezers' that use ultrasound beams to grip and manipulate tiny clusters of cells under electronic, push-button control could lead to life-changing medical advances, such as better cartilage implants that reduce the need for knee replacement operations.

31 May 2014

Amgen presents extended analysis of PEAK study data at ASCO

Amgen today announced results from the Phase 2 PEAK study that reinforce the improved overall survival (OS) benefit of panitumumab (Vectibix®) when used in combination with FOLFOX, an oxaliplatin-based chemotherapy regimen, compared to bevacizumab (Avastin) plus FOLFOX as first-line treatment in patients with wild-type RAS metastatic colorectal cancer (mCRC).

31 May 2014

New cancer panel holds promise in detection of previously undetected viral, cancer mutations

Researchers from Sanford Health and Chronix Biomedical today announced that results from a pilot study demonstrating the utility of a new cancer panel to detect previously undetected viral and cancer mutations are to be reported in a poster presentation titled "Detection of novel HPV mutations and chromosomal number imbalance (CNI) in oropharyngeal and laryngeal cancer using next-generation sequencing (NGS)" (Abstract #6072) at the American Society of Clinical Oncology Annual Meeting (ASCO 2014) being held from May 30 through June 3, 2014 in Chicago.

31 May 2014

Experts from ProfNet network available to discuss timely issues in coverage area

Below are experts from the ProfNet network that are available to discuss timely issues in your coverage area. If you are interested in interviewing any of the experts, please contact them via the contact information at the end of the listing.

31 May 2014

Mount Sinai Heart to host four-day symposium on Complex Coronary, Valvular, and Vascular Cases

Mount Sinai Heart will host its innovative and prestigious 17th Annual 2014 Live Symposium of Complex Coronary, Valvular, and Vascular Cases June 10-13 at The Mount Sinai Hospital.

31 May 2014

OncLive announces 2014 Giants of Cancer Care

OncLive today announced the 2014 Giants of Cancer Care, 16 heroes in the oncology field whose careers have been dedicated to improving or prolonging the lives of those with cancer. The second annual Giants of Cancer Care class will be honored during a special reception tonight in Chicago.

31 May 2014

New data on Gilotrif and investigational compounds to be presented at 50th ASCO annual meeting

Boehringer Ingelheim today announced that new data will be presented from 7 abstracts for Gilotrif (afatinib) and investigational compounds, including nintedanib and BI 836845, from its oncology pipeline at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL, on May 30 – June 3, 2014.

31 May 2014

VA Chief Shinseki vows changes Amid calls for his ouster

One day after a preliminary Inspector General report confirmed secret waiting lists at a Phoenix veterans hospital, Veterans Affairs Secretary Eric Shinseki pledged to keep VA hospitals open nights and weekends if necessary to see veterans who have been unable to get care.

31 May 2014

Promedior reports positive preliminary data from PRM-151 Phase 2 trial for myelofibrosis

Promedior, Inc., today announced positive preliminary data from its Phase 2 trial of PRM-151, an anti-fibrotic immunotherapy, in patients with myelofibrosis which demonstrated biologic activity with improvements across clinically relevant measures, including bone marrow fibrosis, hemoglobin, platelets, spleen, and symptoms.

31 May 2014

Research roundup: End-of-life preferences; surviving trauma when older; ACA's big waiver for states

Policies and practices that promote advance care planning and advance directive completion implicitly assume that patients' choices for end-of-life (EOL) care are stable over time, even with changes in health status.

31 May 2014

Pivotal Therapeutics reports reduced revenue in first quarter 2014

Pivotal Therapeutics Inc., ("Pivotal" or the "Company"), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced its operational highlights and financial results for the three months ended March 31, 2014.

31 May 2014

Talyst to showcase acute care pharmacy automation solutions, software products at ASHP Summer Meeting

Talyst, a market leader in pharmacy automation and 340B solutions, will be exhibiting at the 2014 American Society of Health-System Pharmacists (ASHP) Summer Meeting in Las Vegas, NV.

31 May 2014

Astellas seeks marketing approval for Flublok recombinant influenza vaccine in Japan

Protein Sciences Corporation announced today that Astellas Pharma has submitted an application for marketing approval of recombinant influenza HA vaccine ASP7374 (marketed as Flublok® in the United States by Protein Sciences) to the Ministry of Health, Labour and Welfare in Japan for the prevention of influenza.

31 May 2014

MedPage Today launches Video Conference Reporter for real-time coverage of major oncology meetings

MedPage Today, a property of Everyday Health, Inc. (NYSE: EVDY), announces the launch of "Video Conference Reporter," to provide recorded real-time video coverage of major oncology research presented at leading scientific sessions worldwide.

31 May 2014

Lawmaker pushes mental health reform bill in the wake of recent Calif. shooting

Rep. Tim Murphy, R-Pa., held a forum Thursday in an effort to build momentum and consensus around this legislation.

31 May 2014

U.S. Court awards Teva favorable decision for generic Celebrex

Teva Pharmaceutical Industries Ltd. announced that the U.S. District Court for the Northern District of West Virginia denied a motion filed by Mylan and issued an opinion and order affirming a decision by the FDA under which Teva should receive sole 180-day "first-to-file" exclusivity for generic Celebrex® (celecoxib) 100, 200 and 400 mg capsules.

31 May 2014

Healthcare News and Research

Latest Healthcare News and Research

Myriad myRisk test solves overlap dilemma between hereditary cancer syndromes

Pivotal clinical validation study of Myriad myPath Melanoma test presented at ASCO 2014

ImmunoGen reports favorable clinical results from STARLYTE Phase II trial of SAR3419 for DLBCL

Memorial Sloan Kettering Cancer Center, Quest Diagnostics partner for cancer tests

Ultrasound beam 'tweezers' can grip and manipulate tiny clusters of cells

Amgen presents extended analysis of PEAK study data at ASCO

New cancer panel holds promise in detection of previously undetected viral, cancer mutations

Experts from ProfNet network available to discuss timely issues in coverage area

Mount Sinai Heart to host four-day symposium on Complex Coronary, Valvular, and Vascular Cases

OncLive announces 2014 Giants of Cancer Care

New data on Gilotrif and investigational compounds to be presented at 50th ASCO annual meeting

VA Chief Shinseki vows changes Amid calls for his ouster

Promedior reports positive preliminary data from PRM-151 Phase 2 trial for myelofibrosis

Research roundup: End-of-life preferences; surviving trauma when older; ACA's big waiver for states

Pivotal Therapeutics reports reduced revenue in first quarter 2014

Talyst to showcase acute care pharmacy automation solutions, software products at ASHP Summer Meeting

Astellas seeks marketing approval for Flublok recombinant influenza vaccine in Japan

MedPage Today launches Video Conference Reporter for real-time coverage of major oncology meetings

Lawmaker pushes mental health reform bill in the wake of recent Calif. shooting

U.S. Court awards Teva favorable decision for generic Celebrex

Event guide: 3rd Measuring Patient Engagement Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Healthcare News and Research

Latest Healthcare News and Research

Event guide: 3rd Measuring Patient Engagement Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Newsletters you may be interested in